McAlpine, K. (2025) “Adjuvant pembrolizumab following kidney cancer surgery : A novel patient decision aid to facilitate shared decision-making”, Canadian Urological Association Journal, 19(6), pp. 205–7. doi: 10.5489/cuaj.9073.